ISSN: 2090-3111

Journal Home

Prostate Cancer Q2 Unclaimed

John Wiley and Sons Ltd United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Prostate Cancer is a journal indexed in SJR in Oncology and Cancer Research with an H index of 16. It is an CC BY Journal with a Single blind Peer Review review system, and It has a price of 922,5 €. The scope of the journal is focused on male urogenital diseases, prostatic neoplasms, prostate cancer. It has an SJR impact factor of 0,56 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,56.

Type: Journal

Type of Copyright: CC BY

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

Categories: Urology (Q2) Cancer Research (Q3) Oncology (Q3)

Price

922,5 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

0,56

SJR Impact factor

16

H Index

4

Total Docs (Last Year)

19

Total Docs (3 years)

116

Total Refs

20

Total Cites (3 years)

19

Citable Docs (3 years)

1.36

Cites/Doc (2 years)

29.0

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

International Journal of Oncology Q2
Cancer Cytopathology Q2
Cancer Causes & Control Q2
BMC Cancer Q2
Current Opinion in Oncology Q2

Compare this journals

Aims and Scope

Male urogenital diseases Prostatic neoplasms Prostate cancer